Sofgen Pharma S.A. (PROCF)
OTCMKTS
· Delayed Price · Currency is USD
0.0242
0.00 (0.00%)
Mar 5, 2026, 9:30 AM EST
Sofgen Pharma Revenue
In the year 2023, Sofgen Pharma had annual revenue of $423.75M with 5.10% growth. Sofgen Pharma had revenue of $118.41M in the quarter ending September 30, 2023, with 7.25% growth.
Revenue
423.75M
Revenue Growth
+5.10%
P/S Ratio
0.13
Revenue / Employee
84.75K
Employees
5,000
Market Cap
55.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 423.75M | 20.55M | 5.10% |
| Dec 31, 2022 | 403.20M | -536.00K | -0.13% |
| Jan 1, 2022 | 403.74M | 72.27M | 21.80% |
| Dec 31, 2020 | 331.47M | 6.68M | 2.06% |
| Jan 1, 2020 | 324.79M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Radnostix | 14.07M |
| Growth Stalk Holdings | 583.34K |
| Healthy Extracts | 3.59M |
| Jushi Holdings | 260.43M |
| MariMed | 157.38M |
| Earth Science Tech | 34.87M |
| Kaya Holdings | 26.69K |
| The Cannabist Company Holdings | 349.84M |